ArrowMark Colorado Holdings’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,812,710
| Closed | -$61.6M | – | 374 |
|
|
2021
Q3 | $61.6M | Buy |
1,812,710
+259,427
| +17% | +$8.82M | 0.48% | 63 |
|
|
2021
Q2 | $56.9M | Sell |
1,553,283
-57,400
| -4% | -$2.1M | 0.43% | 73 |
|
|
2021
Q1 | $72.2M | Buy |
1,610,683
+60,183
| +4% | +$2.7M | 0.54% | 57 |
|
|
2020
Q4 | $88.5M | Buy |
1,550,500
+10,282
| +0.7% | +$587K | 0.69% | 53 |
|
|
2020
Q3 | $79M | Sell |
1,540,218
-28,451
| -2% | -$1.46M | 0.75% | 44 |
|
|
2020
Q2 | $93.7M | Sell |
1,568,669
-115,925
| -7% | -$6.92M | 0.97% | 31 |
|
|
2020
Q1 | $69.4M | Sell |
1,684,594
-8,662
| -0.5% | -$357K | 0.91% | 38 |
|
|
2019
Q4 | $105M | Sell |
1,693,256
-66,594
| -4% | -$4.14M | 0.94% | 39 |
|
|
2019
Q3 | $59.7M | Buy |
1,759,850
+1,215,553
| +223% | +$41.3M | 0.6% | 59 |
|
|
2019
Q2 | $12.3M | Buy |
544,297
+150,365
| +38% | +$3.39M | 0.12% | 148 |
|
|
2019
Q1 | $9.14M | Buy |
393,932
+37,975
| +11% | +$881K | 0.09% | 177 |
|
|
2018
Q4 | $7.47M | Buy |
355,957
+24,967
| +8% | +$524K | 0.08% | 192 |
|
|
2018
Q3 | $12.8M | Buy |
330,990
+16,593
| +5% | +$642K | 0.11% | 166 |
|
|
2018
Q2 | $12.4M | Buy |
+314,397
| New | +$12.4M | 0.11% | 165 |
|
|
2018
Q1 | – | Sell |
-231,760
| Closed | -$5.25M | – | 329 |
|
|
2017
Q4 | $5.25M | Buy |
231,760
+30,475
| +15% | +$691K | 0.05% | 205 |
|
|
2017
Q3 | $3.82M | Buy |
+201,285
| New | +$3.82M | 0.04% | 216 |
|